Unveiling Insights on Paychex – Analyst Findings

Large-cap Consumer Discretionary company Paychex has moved 1.5% so far today on a volume of 2,637,724, compared to its average of 1,867,666. In contrast, the S&P 500 index moved -1.0%.

Paychex trades -1.31% away from its average analyst target price of $121.11 per share. The 15 analysts following the stock have set target prices ranging from $111.0 to $130.0, and on average have given Paychex a rating of hold.

Anyone interested in buying PAYX should be aware of the facts below:

  • Paychex's current price is 289.4% above its Graham number of $30.69, which implies that at its current valuation it does not offer a margin of safety

  • Paychex has moved 7.8% over the last year, and the S&P 500 logged a change of 20.1%

  • Based on its trailing earnings per share of 4.59, Paychex has a trailing 12 month Price to Earnings (P/E) ratio of 26.0 while the S&P 500 average is 15.97

  • PAYX has a forward P/E ratio of 24.0 based on its forward 12 month price to earnings (EPS) of $4.98 per share

  • The company has a price to earnings growth (PEG) ratio of 3.29 — a number near or below 1 signifying that Paychex is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 11.48 compared to its sector average of 4.24

  • Paychex, Inc. provides integrated human capital management solutions for human resources (HR), payroll, benefits, and insurance services for small to medium-sized businesses in the United States, Europe, and India.

  • Based in Rochester, the company has 16,000 full time employees and a market cap of $43.02 Billion. Paychex currently returns an annual dividend yield of 3.0%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS